Breaking News Instant updates and real-time market news.

BPOSY

Bpost

$0.00 /

+ (+0.00%)

13:40
01/21/21
01/21
13:40
01/21/21
13:40

Bpost price target lowered to EUR 11.40 from EUR 11.75 at Berenberg

Berenberg analyst William Howard lowered the firm's price target on Bpost to EUR 11.40 from EUR 11.75 and keeps a Buy rating on the shares.

BPOSY Bpost
$0.00 /

+ (+0.00%)

12/15/20 ING Bank
Bpost upgraded to Buy from Hold at ING Bank
12/09/20 Barclays
Bpost price target lowered to EUR 9.10 from EUR 9.60 at Barclays
12/09/20 UBS
Bpost price target lowered to EUR 9.85 from EUR 10.50 at UBS
11/26/20 Berenberg
Bpost upgraded to Buy from Hold at Berenberg

TODAY'S FREE FLY STORIES

Conference/Events
Spirit Realty management to meet virtually with JPMorgan » 10:40
03/01/21
03/01
10:40
03/01/21
10:40
SRC

Spirit Realty

$43.74 /

+0.785 (+1.83%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SRC Spirit Realty
$43.74 /

+0.785 (+1.83%)

SRC Spirit Realty
$43.74 /

+0.785 (+1.83%)

02/26/21 UBS
Spirit Realty upgraded to Neutral from Sell at UBS
12/30/20 Truist
Spirit Realty price target raised to $43 from $39 at Truist
12/16/20 Baird
Spirit Realty reinstated with a Neutral at Baird
10/16/20
Fly Intel: Top five analyst initiations
SRC Spirit Realty
$43.74 /

+0.785 (+1.83%)

  • 09
    Jun
SRC Spirit Realty
$43.74 /

+0.785 (+1.83%)

On The Fly
Macau GGR spikes over 135% in February vs. last year » 10:38
03/01/21
03/01
10:38
03/01/21
10:38
LVS

Las Vegas Sands

$63.20 /

+0.58 (+0.93%)

, MLCO

Melco Resorts & Entertainment

$21.54 /

-0.13 (-0.60%)

, MGM

MGM Resorts

$38.29 /

+0.5 (+1.32%)

, WYNN

Wynn Resorts

$133.01 /

+1.43 (+1.09%)

Casino companies…

ShowHide Related Items >><<
LVS Las Vegas Sands
$63.20 /

+0.58 (+0.93%)

MLCO Melco Resorts & Entertainment
$21.54 /

-0.13 (-0.60%)

MGM MGM Resorts
$38.29 /

+0.5 (+1.32%)

WYNN Wynn Resorts
$133.01 /

+1.43 (+1.09%)

LVS Las Vegas Sands
$63.20 /

+0.58 (+0.93%)

02/09/21 Morgan Stanley
Morgan Stanley says legalized sports betting in Texas this year has 'slim' odds
02/08/21
Fly Intel: Top five analyst downgrades
02/08/21 BofA
Las Vegas Sands downgraded to Neutral from Buy at BofA
02/08/21 BofA
Las Vegas Sands downgraded to Neutral from Buy at BofA
MLCO Melco Resorts & Entertainment
$21.54 /

-0.13 (-0.60%)

02/25/21 CLSA
Melco Resorts & Entertainment upgraded to Outperform from Underperform at CLSA
01/07/21 Macquarie
Melco Resorts & Entertainment downgraded to Neutral from Outperform at Macquarie
11/17/20 JPMorgan
Melco Resorts & Entertainment price target raised to $25 from $23 at JPMorgan
11/05/20 Roth Capital
Roth Capital trims price target on 'go-to Macau name' Melco Resorts to $30
MGM MGM Resorts
$38.29 /

+0.5 (+1.32%)

02/23/21
Fly Intel: Top five analyst upgrades
02/23/21 Argus
MGM Resorts upgraded to Buy from Hold at Argus
02/23/21 Argus
MGM Resorts upgraded to Buy from Hold at Argus
02/11/21 Truist
MGM Resorts price target raised to $38 from $33 at Truist
WYNN Wynn Resorts
$133.01 /

+1.43 (+1.09%)

02/09/21 Morgan Stanley
Morgan Stanley says legalized sports betting in Texas this year has 'slim' odds
02/08/21 Credit Suisse
Wynn Resorts price target raised to $99 from $80 at Credit Suisse
02/08/21 Deutsche Bank
Wynn Resorts price target raised to $125 from $120 at Deutsche Bank
02/05/21 Citi
Wynn Resorts upgraded to Neutral from Sell at Citi
LVS Las Vegas Sands
$63.20 /

+0.58 (+0.93%)

MLCO Melco Resorts & Entertainment
$21.54 /

-0.13 (-0.60%)

MGM MGM Resorts
$38.29 /

+0.5 (+1.32%)

WYNN Wynn Resorts
$133.01 /

+1.43 (+1.09%)

  • 09
    Feb
LVS Las Vegas Sands
$63.20 /

+0.58 (+0.93%)

MGM MGM Resorts
$38.29 /

+0.5 (+1.32%)

WYNN Wynn Resorts
$133.01 /

+1.43 (+1.09%)

LVS Las Vegas Sands
$63.20 /

+0.58 (+0.93%)

MLCO Melco Resorts & Entertainment
$21.54 /

-0.13 (-0.60%)

MGM MGM Resorts
$38.29 /

+0.5 (+1.32%)

WYNN Wynn Resorts
$133.01 /

+1.43 (+1.09%)

LVS Las Vegas Sands
$63.20 /

+0.58 (+0.93%)

MLCO Melco Resorts & Entertainment
$21.54 /

-0.13 (-0.60%)

MGM MGM Resorts
$38.29 /

+0.5 (+1.32%)

WYNN Wynn Resorts
$133.01 /

+1.43 (+1.09%)

Conference/Events
Sonic Automotive management to meet virtually with JPMorgan » 10:38
03/01/21
03/01
10:38
03/01/21
10:38
SAH

Sonic Automotive

$47.06 /

+0.78 (+1.69%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SAH Sonic Automotive
$47.06 /

+0.78 (+1.69%)

SAH Sonic Automotive
$47.06 /

+0.78 (+1.69%)

01/15/21 JPMorgan
Sonic Automotive upgraded to Overweight with $55 target at JPMorgan
01/15/21 JPMorgan
Sonic Automotive upgraded to Overweight from Neutral at JPMorgan
12/07/20 Morgan Stanley
Morgan Stanley upgrades Asbury, downgrades Lithia in auto dealer rating shake-up
11/17/20 BofA
Adient, Aptiv get double downgrades as BofA reshuffles auto industry ratings
SAH Sonic Automotive
$47.06 /

+0.78 (+1.69%)

SAH Sonic Automotive
$47.06 /

+0.78 (+1.69%)

Periodicals
Amazon Prime Video signs Nordics output deal with Eros STX Global, Variety says » 10:36
03/01/21
03/01
10:36
03/01/21
10:36
AMZN

Amazon.com

$3,104.63 /

+11.965 (+0.39%)

, ESGC

Eros STX Global

$1.93 /

+0.085 (+4.62%)

Amazon Prime Video (AMZN)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMZN Amazon.com
$3,104.63 /

+11.965 (+0.39%)

ESGC Eros STX Global
$1.93 /

+0.085 (+4.62%)

AMZN Amazon.com
$3,104.63 /

+11.965 (+0.39%)

02/26/21 B. Riley Securities
Plug Power recent selloff provides relative discount, says B. Riley
02/17/21 Needham
Kornit Digital price target raised to $125 from $76 at Needham
02/17/21 Morgan Stanley
Roku price target raised to $275 from $200 at Morgan Stanley
02/17/21 Citi
Citi boosts target on favorite internet stock Amazon to $3,750
ESGC Eros STX Global
$1.93 /

+0.085 (+4.62%)

AMZN Amazon.com
$3,104.63 /

+11.965 (+0.39%)

ESGC Eros STX Global
$1.93 /

+0.085 (+4.62%)

AMZN Amazon.com
$3,104.63 /

+11.965 (+0.39%)

ESGC Eros STX Global
$1.93 /

+0.085 (+4.62%)

AMZN Amazon.com
$3,104.63 /

+11.965 (+0.39%)

AMZN Amazon.com
$3,104.63 /

+11.965 (+0.39%)

ESGC Eros STX Global
$1.93 /

+0.085 (+4.62%)

Conference/Events
Pool Corp. management to meet virtually with Sidoti » 10:34
03/01/21
03/01
10:34
03/01/21
10:34
POOL

Pool Corp.

$335.82 /

+0.8 (+0.24%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
POOL Pool Corp.
$335.82 /

+0.8 (+0.24%)

POOL Pool Corp.
$335.82 /

+0.8 (+0.24%)

02/10/21 Berenberg
Leslie's initiated with a Hold at Berenberg
01/15/21 Jefferies
Pool Corp. price target raised to $400 from $350 at Jefferies
12/31/20 William Blair
Azek, Trex among Blair's top Specialty Distribution ideas for 2021
11/11/20 Stephens
Pool Corp. resumed with an Equal Weight at Stephens
POOL Pool Corp.
$335.82 /

+0.8 (+0.24%)

POOL Pool Corp.
$335.82 /

+0.8 (+0.24%)

POOL Pool Corp.
$335.82 /

+0.8 (+0.24%)

Conference/Events
AMN Healthcare management to meet virtually with Sidoti » 10:33
03/01/21
03/01
10:33
03/01/21
10:33
AMN

AMN Healthcare

$73.85 /

+0.96 (+1.32%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMN AMN Healthcare
$73.85 /

+0.96 (+1.32%)

02/22/21 BMO Capital
AMN Healthcare price target raised to $86 from $81 at BMO Capital
02/19/21 Truist
AMN Healthcare price target raised to $95 from $84 at Truist
01/20/21 Truist
AMN Healthcare price target raised to $84 from $78 at Truist
01/19/21 BMO Capital
AMN Healthcare price target raised to $81 from $72 at BMO Capital
AMN AMN Healthcare
$73.85 /

+0.96 (+1.32%)

Recommendations
InvaGen takeout 'may still be in play' at Avenue, says H.C. Wainwright » 10:32
03/01/21
03/01
10:32
03/01/21
10:32
ATXI

Avenue Therapeutics

$5.00 /

+0.29 (+6.16%)

After Avenue Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATXI Avenue Therapeutics
$5.00 /

+0.29 (+6.16%)

ATXI Avenue Therapeutics
$5.00 /

+0.29 (+6.16%)

02/17/21 Dawson James
Fortress Biotech price target raised to $21 from $16 at Dawson James
10/12/20 H.C. Wainwright
Avenue downgraded to Neutral on merger uncertainty at H.C. Wainwright
10/12/20 H.C. Wainwright
Avenue Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
10/12/20 H.C. Wainwright
H.C. Wainwright cuts Fortress Biotech target to $10 after Avenue's 'bizarre' CRL
ATXI Avenue Therapeutics
$5.00 /

+0.29 (+6.16%)

Hot Stocks
FedEx begins shipping newly approved Covid vaccine on behalf of McKesson » 10:30
03/01/21
03/01
10:30
03/01/21
10:30
FDX

FedEx

$259.43 /

+4.4 (+1.73%)

, MCK

McKesson

$172.80 /

+3.99 (+2.36%)

FedEx Express, a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FDX FedEx
$259.43 /

+4.4 (+1.73%)

MCK McKesson
$172.80 /

+3.99 (+2.36%)

FDX FedEx
$259.43 /

+4.4 (+1.73%)

01/07/21 Wolfe Research
FedEx downgraded to Peer Perform from Outperform at Wolfe Research
12/30/20 Argus
FedEx price target raised to $305 from $270 at Argus
12/18/20 Raymond James
FedEx price target raised to $305 from $280 at Raymond James
12/18/20 Morgan Stanley
FedEx's 'modest' Q2 beat likely falls short of high bar, says Morgan Stanley
MCK McKesson
$172.80 /

+3.99 (+2.36%)

02/03/21 Credit Suisse
McKesson price target raised to $192 from $178 at Credit Suisse
02/03/21 Deutsche Bank
McKesson price target raised to $231 from $222 at Deutsche Bank
02/03/21 Mizuho
McKesson price target raised to $190 from $178 at Mizuho
02/01/21 Cowen
McKesson price target raised to $210 from $186 at Cowen
FDX FedEx
$259.43 /

+4.4 (+1.73%)

MCK McKesson
$172.80 /

+3.99 (+2.36%)

FDX FedEx
$259.43 /

+4.4 (+1.73%)

MCK McKesson
$172.80 /

+3.99 (+2.36%)

FDX FedEx
$259.43 /

+4.4 (+1.73%)

MCK McKesson
$172.80 /

+3.99 (+2.36%)

FDX FedEx
$259.43 /

+4.4 (+1.73%)

MCK McKesson
$172.80 /

+3.99 (+2.36%)

General news
Treasury Action: yields are mixed despite a hefty rally on Wall Street » 10:30
03/01/21
03/01
10:30
03/01/21
10:30

Treasury Action: yields…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Avenue Therapeutics reports PDUFA date of April 12, 2021 set for IV Tramadol » 10:28
03/01/21
03/01
10:28
03/01/21
10:28
ATXI

Avenue Therapeutics

$5.00 /

+0.29 (+6.16%)

In a regulatory filing…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATXI Avenue Therapeutics
$5.00 /

+0.29 (+6.16%)

ATXI Avenue Therapeutics
$5.00 /

+0.29 (+6.16%)

02/17/21 Dawson James
Fortress Biotech price target raised to $21 from $16 at Dawson James
10/12/20 H.C. Wainwright
Avenue downgraded to Neutral on merger uncertainty at H.C. Wainwright
10/12/20 H.C. Wainwright
Avenue Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
10/12/20 H.C. Wainwright
H.C. Wainwright cuts Fortress Biotech target to $10 after Avenue's 'bizarre' CRL
ATXI Avenue Therapeutics
$5.00 /

+0.29 (+6.16%)

Conference/Events
Jones Lang LaSalle participates in a conference call with BMO Capital » 10:27
03/01/21
03/01
10:27
03/01/21
10:27
JLL

Jones Lang LaSalle

$178.25 /

+3.765 (+2.16%)

Conference call with Bob…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JLL Jones Lang LaSalle
$178.25 /

+3.765 (+2.16%)

JLL Jones Lang LaSalle
$178.25 /

+3.765 (+2.16%)

02/26/21 JPMorgan
Jones Lang LaSalle price target raised to $200 from $176 at JPMorgan
01/25/21 Goldman Sachs
Jones Lang LaSalle initiated with a Buy at Goldman Sachs
12/21/20 JPMorgan
Jones Lang LaSalle price target raised to $172 from $132 at JPMorgan
10/07/20 Keefe Bruyette
Jones Lang LaSalle downgraded to Market Perform at Keefe Bruyette
JLL Jones Lang LaSalle
$178.25 /

+3.765 (+2.16%)

Options
Macy's call volume above normal and directionally bullish » 10:25
03/01/21
03/01
10:25
03/01/21
10:25
M

Macy's

$16.06 /

+0.86 (+5.66%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
M Macy's
$16.06 /

+0.86 (+5.66%)

M Macy's
$16.06 /

+0.86 (+5.66%)

02/24/21 Credit Suisse
Macy's price target raised to $13 from $7 at Credit Suisse
02/24/21 Deutsche Bank
Macy's price target raised to $16 from $15 at Deutsche Bank
02/18/21 Morgan Stanley
Macy's price target raised to $11 from $6 at Morgan Stanley
01/21/21 Deutsche Bank
Macy's price target raised to $15 from $9 at Deutsche Bank
M Macy's
$16.06 /

+0.86 (+5.66%)

M Macy's
$16.06 /

+0.86 (+5.66%)

M Macy's
$16.06 /

+0.86 (+5.66%)

M Macy's
$16.06 /

+0.86 (+5.66%)

Conference/Events
UBS consumer goods analysts to hold an analyst/industry conference call » 10:25
03/01/21
03/01
10:25
03/01/21
10:25

Consumer Goods Analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Vocera to hold virtual investor briefing » 10:25
03/01/21
03/01
10:25
03/01/21
10:25
VCRA

Vocera

$44.04 /

+1.1 (+2.56%)

Virtual Investor Briefing…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VCRA Vocera
$44.04 /

+1.1 (+2.56%)

VCRA Vocera
$44.04 /

+1.1 (+2.56%)

02/12/21 Piper Sandler
Piper boosts Vocera target to $56, says buy into March 1 investor day
02/12/21 Baird
Vocera upgraded to Outperform from Neutral at Baird
02/12/21 Craig-Hallum
Vocera price target raised to $50 from $40 at Craig-Hallum
02/12/21 William Blair
Vocera has good visibility into 'solid' 2021, says William Blair
VCRA Vocera
$44.04 /

+1.1 (+2.56%)

VCRA Vocera
$44.04 /

+1.1 (+2.56%)

Conference/Events
e.l.f. Beauty participates in a conference call with JPMorgan » 10:25
03/01/21
03/01
10:25
03/01/21
10:25
ELF

e.l.f. Beauty

$26.45 /

+0.73 (+2.84%)

Beverage, Household &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ELF e.l.f. Beauty
$26.45 /

+0.73 (+2.84%)

ELF e.l.f. Beauty
$26.45 /

+0.73 (+2.84%)

02/04/21
e.l.f. Beauty price target raised to $30 from $25 at Truist
01/20/21 Piper Sandler
e.l.f. Beauty downgraded to Neutral from Overweight at Piper Sandler
10/06/20 Piper Sandler
Piper teen survey shows Snap, Amazon and Apple remain favorites
08/06/20 Truist
e.l.f. Beauty price target raised to $25 from $20 at Truist
ELF e.l.f. Beauty
$26.45 /

+0.73 (+2.84%)

ELF e.l.f. Beauty
$26.45 /

+0.73 (+2.84%)

Conference/Events
JPMorgan transports/logistics analyst to hold analyst/industry conference call » 10:25
03/01/21
03/01
10:25
03/01/21
10:25

Transports &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
UBS technology analyst to hold lan analyst/industry conference call » 10:25
03/01/21
03/01
10:25
03/01/21
10:25

Technology Analyst Arcuri…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Upgrade
BYD upgraded to Buy from Neutral at Goldman Sachs » 10:22
03/01/21
03/01
10:22
03/01/21
10:22
BYDDF

BYD

$0.00 /

+ (+0.00%)

Goldman Sachs analyst Fei…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BYDDF BYD
$0.00 /

+ (+0.00%)

11/09/20 JPMorgan
BYD downgraded to Neutral from Overweight at JPMorgan
09/01/20 Jefferies
BYD upgraded to Buy from Hold at Jefferies
06/04/20 JPMorgan
BYD upgraded to Overweight from Underweight at JPMorgan
04/29/20 Jefferies
BYD A shares upgraded to Buy from Hold at Jefferies
Conference/Events
The Genome Partnership to hold a virtual meeting » 10:21
03/01/21
03/01
10:21
03/01/21
10:21
NSTG

NanoString

$71.00 /

+0.98 (+1.40%)

, TWST

Twist Bioscience

$149.86 /

+12.12 (+8.80%)

, PACB

Pacific Biosciences

$34.91 /

+4.34 (+14.20%)

, QGEN

Qiagen

$49.89 /

-0.16 (-0.32%)

, TXG

10x Genomics

$179.29 /

+1.32 (+0.74%)

, CDXS

Codexis

$23.24 /

+1.06 (+4.78%)

, PKI

PerkinElmer

$128.65 /

+2.46 (+1.95%)

, ILMN

Illumina

$447.82 /

+8.24 (+1.87%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, BNGO

Bionano Genomics

$10.01 /

+0.275 (+2.82%)

Advances in Genome…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NSTG NanoString
$71.00 /

+0.98 (+1.40%)

TWST Twist Bioscience
$149.86 /

+12.12 (+8.80%)

PACB Pacific Biosciences
$34.91 /

+4.34 (+14.20%)

QGEN Qiagen
$49.89 /

-0.16 (-0.32%)

TXG 10x Genomics
$179.29 /

+1.32 (+0.74%)

CDXS Codexis
$23.24 /

+1.06 (+4.78%)

PKI PerkinElmer
$128.65 /

+2.46 (+1.95%)

ILMN Illumina
$447.82 /

+8.24 (+1.87%)

RHHBY Roche
$0.00 /

+ (+0.00%)

BNGO Bionano Genomics
$10.01 /

+0.275 (+2.82%)

NSTG NanoString
$71.00 /

+0.98 (+1.40%)

01/11/21 Baird
NanoString price target raised to $70 from $60 at Baird
01/06/21 Cowen
NanoString upgraded to Outperform with $75 target at Cowen
01/06/21 Cowen
NanoString upgraded to Outperform from Market Perform at Cowen
12/02/20 JPMorgan
NanoString price target raised to $60 from $45 at JPMorgan
TWST Twist Bioscience
$149.86 /

+12.12 (+8.80%)

02/05/21 Baird
Twist Bioscience price target raised to $200 from $125 at Baird
02/05/21 JPMorgan
Twist Bioscience downgraded to Underweight from Neutral at JPMorgan
01/04/21 Evercore ISI
Evercore ISI cuts Twist Bioscience to In Line, says new verticals take time
01/04/21 Evercore ISI
Twist Bioscience downgraded to In Line from Outperform at Evercore ISI
PACB Pacific Biosciences
$34.91 /

+4.34 (+14.20%)

02/11/21 Cantor Fitzgerald
Pacific Biosciences price target raised to $62 from $45 at Cantor Fitzgerald
02/11/21 Piper Sandler
Pacific Biosciences upgraded to Overweight from Neutral at Piper Sandler
01/15/21 Piper Sandler
Pacific Biosciences price target raised to $20 from $12 at Piper Sandler
01/12/21 Cantor Fitzgerald
Pacific Biosciences price target raised to $45 from $25 at Cantor Fitzgerald
QGEN Qiagen
$49.89 /

-0.16 (-0.32%)

02/19/21 Berenberg
Qiagen price target raised to EUR 56 from EUR 52 at Berenberg
02/09/21 William Blair
Quidel, Qiagen merger would not make sense, says William Blair
02/09/21 Wells Fargo
Qiagen shares should be sold on latest merger talk, says Wells Fargo
02/09/21 Citi
Merger with Qiagen would benefit Quidel, says Citi
TXG 10x Genomics
$179.29 /

+1.32 (+0.74%)

02/18/21 Cowen
10x Genomics price target raised to $200 from $155 at Cowen
02/18/21 JPMorgan
10x Genomics price target raised to $195 from $160 at JPMorgan
02/18/21 Citi
10x Genomics price target raised to $240 from $195 at Citi
12/16/20 Citi
10x Genomics price target raised to $195 from $165 at Citi
CDXS Codexis
$23.24 /

+1.06 (+4.78%)

06:53 Today Stifel
Codexis initiated with a Buy at Stifel
12/30/20 Benchmark
Codexis price target raised to $29 from $21 at Benchmark
07/15/20 Stephens
Codexis resumed with an Overweight at Stephens
03/10/20 Benchmark
Codexis initiated with a Buy at Benchmark
PKI PerkinElmer
$128.65 /

+2.46 (+1.95%)

02/03/21 Citi
PerkinElmer price target raised to $155 from $150 at Citi
01/07/21 Piper Sandler
Oxford Immunotec downgraded to Neutral from Overweight at Piper Sandler
01/07/21 Wells Fargo
PerkinElmer upgraded to Overweight from Equal Weight at Wells Fargo
01/07/21 Wells Fargo
PerkinElmer upgraded to Overweight from Equal Weight at Wells Fargo
ILMN Illumina
$447.82 /

+8.24 (+1.87%)

02/16/21 BTIG
Illumina price target raised to $570 from $410 at BTIG
02/12/21 Piper Sandler
Illumina price target raised to $510 from $415 at Piper Sandler
02/12/21 Cowen
Illumina price target raised to $460 from $385 at Cowen
12/22/20
Fly Intel: Top five analyst upgrades
RHHBY Roche
$0.00 /

+ (+0.00%)

02/25/21 Berenberg
Roche price target lowered to CHF 320 from CHF 325 at Berenberg
02/24/21 Morgan Stanley
Roche price target lowered to CHF 345 from CHF 365 at Morgan Stanley
02/23/21 BofA
BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list
02/17/21 UBS
UBS downgrades Roche to Neutral on risk to 2022 estimates
BNGO Bionano Genomics
$10.01 /

+0.275 (+2.82%)

02/08/21 Oppenheimer
Bionano Genomics price target raised to $15 from $1.50 at Oppenheimer
01/26/21 Ladenburg
Bionano Genomics price target raised to $14 from $1.25 at Ladenburg
01/22/21 Maxim
Bionano Genomics price target raised to $14 from $2 at Maxim
12/04/20 Roth Capital
Bionano Genomics downgraded to Neutral from Buy at Roth Capital
NSTG NanoString
$71.00 /

+0.98 (+1.40%)

TWST Twist Bioscience
$149.86 /

+12.12 (+8.80%)

PACB Pacific Biosciences
$34.91 /

+4.34 (+14.20%)

QGEN Qiagen
$49.89 /

-0.16 (-0.32%)

TXG 10x Genomics
$179.29 /

+1.32 (+0.74%)

CDXS Codexis
$23.24 /

+1.06 (+4.78%)

PKI PerkinElmer
$128.65 /

+2.46 (+1.95%)

ILMN Illumina
$447.82 /

+8.24 (+1.87%)

RHHBY Roche
$0.00 /

+ (+0.00%)

BNGO Bionano Genomics
$10.01 /

+0.275 (+2.82%)

  • 20
    Jan
  • 08
    Jan
  • 03
    Dec
  • 03
    Dec
  • 11
    Nov
  • 08
    Oct
  • 11
    Sep
  • 12
    Aug
  • 04
    Jun
PACB Pacific Biosciences
$34.91 /

+4.34 (+14.20%)

QGEN Qiagen
$49.89 /

-0.16 (-0.32%)

ILMN Illumina
$447.82 /

+8.24 (+1.87%)

RHHBY Roche
$0.00 /

+ (+0.00%)

NSTG NanoString
$71.00 /

+0.98 (+1.40%)

TWST Twist Bioscience
$149.86 /

+12.12 (+8.80%)

PACB Pacific Biosciences
$34.91 /

+4.34 (+14.20%)

QGEN Qiagen
$49.89 /

-0.16 (-0.32%)

TXG 10x Genomics
$179.29 /

+1.32 (+0.74%)

CDXS Codexis
$23.24 /

+1.06 (+4.78%)

PKI PerkinElmer
$128.65 /

+2.46 (+1.95%)

ILMN Illumina
$447.82 /

+8.24 (+1.87%)

RHHBY Roche
$0.00 /

+ (+0.00%)

BNGO Bionano Genomics
$10.01 /

+0.275 (+2.82%)

PACB Pacific Biosciences
$34.91 /

+4.34 (+14.20%)

QGEN Qiagen
$49.89 /

-0.16 (-0.32%)

PKI PerkinElmer
$128.65 /

+2.46 (+1.95%)

ILMN Illumina
$447.82 /

+8.24 (+1.87%)

BNGO Bionano Genomics
$10.01 /

+0.275 (+2.82%)

Downgrade
RBC downgrades Ontrak to Sector Perform, cuts target to $32 after loss of Aetna » 10:21
03/01/21
03/01
10:21
03/01/21
10:21
OTRK

Ontrak

$32.45 /

-26.68 (-45.12%)

, CVS

CVS Health

$68.88 /

+0.75 (+1.10%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OTRK Ontrak
$32.45 /

-26.68 (-45.12%)

CVS CVS Health
$68.88 /

+0.75 (+1.10%)

OTRK Ontrak
$32.45 /

-26.68 (-45.12%)

10:17 Today RBC Capital
Ontrak downgraded to Sector Perform from Outperform at RBC Capital
01/05/21 Benchmark
GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021
01/04/21 B. Riley Securities
Ontrak price target raised to $110 from $100 at B. Riley Securities
11/18/20 B. Riley Securities
Ontrak initiated with a Buy at B. Riley Securities
CVS CVS Health
$68.88 /

+0.75 (+1.10%)

01/29/21 Jefferies
Carvana, Walmart among 13 additions to Jefferies Franchise Picks list
01/22/21 Baird
Tabula Rasa HealthCare may have lost MTM deal at Aetna, says Baird
01/19/21 JPMorgan
Teladoc remains top 2021 healthcare technology pick at JPMorgan
01/08/21
Fly Intel: Top five analyst upgrades
OTRK Ontrak
$32.45 /

-26.68 (-45.12%)

CVS CVS Health
$68.88 /

+0.75 (+1.10%)

CVS CVS Health
$68.88 /

+0.75 (+1.10%)

CVS CVS Health
$68.88 /

+0.75 (+1.10%)

OTRK Ontrak
$32.45 /

-26.68 (-45.12%)

CVS CVS Health
$68.88 /

+0.75 (+1.10%)

Recommendations
Homology Medicines loses potential source of upside, says Oppenheimer » 10:18
03/01/21
03/01
10:18
03/01/21
10:18
FIXX

Homology Medicines

$11.03 /

+0.28 (+2.60%)

, NVS

Novartis

$86.59 /

+0.57 (+0.66%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FIXX Homology Medicines
$11.03 /

+0.28 (+2.60%)

NVS Novartis
$86.59 /

+0.57 (+0.66%)

FIXX Homology Medicines
$11.03 /

+0.28 (+2.60%)

12/14/20 H.C. Wainwright
Homology Medicines transferred with Buy, $30 target at H.C. Wainwright
11/08/20 Oppenheimer
Homology Medicines selloff unjustified in wake of clinical PoC, says Oppenheimer
08/11/20 Oppenheimer
Homology Medicines price target lowered to $27 from $32 at Oppenheimer
08/11/20 H.C. Wainwright
Homology Medicines price target lowered to $30 from $37 at H.C. Wainwright
NVS Novartis
$86.59 /

+0.57 (+0.66%)

02/02/21 Morgan Stanley
Novartis price target lowered to CHF 102 from CHF 104 at Morgan Stanley
02/01/21 Truist
iRhythm price target lowered to $220 from $265 at Truist
02/01/21 Cowen
Novartis downgraded to Market Perform after 'tepid' guidance at Cowen
02/01/21 Cowen
Novartis downgraded to Market Perform from Outperform at Cowen
FIXX Homology Medicines
$11.03 /

+0.28 (+2.60%)

NVS Novartis
$86.59 /

+0.57 (+0.66%)

NVS Novartis
$86.59 /

+0.57 (+0.66%)

FIXX Homology Medicines
$11.03 /

+0.28 (+2.60%)

NVS Novartis
$86.59 /

+0.57 (+0.66%)

Technical Analysis
NASDAQ market internals summary » 10:17
03/01/21
03/01
10:17
03/01/21
10:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
$0.00 /

+ (+0.00%)

Downgrade
Ontrak downgraded to Sector Perform from Outperform at RBC Capital » 10:17
03/01/21
03/01
10:17
03/01/21
10:17
OTRK

Ontrak

$32.50 /

-26.63 (-45.04%)

RBC Capital analyst Sean…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OTRK Ontrak
$32.50 /

-26.63 (-45.04%)

OTRK Ontrak
$32.50 /

-26.63 (-45.04%)

01/05/21 Benchmark
GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021
01/04/21 B. Riley Securities
Ontrak price target raised to $110 from $100 at B. Riley Securities
11/18/20 B. Riley Securities
Ontrak initiated with a Buy at B. Riley Securities
10/02/20 Canaccord
Ontrak analysis points to significant upside for shares, says Canaccord
OTRK Ontrak
$32.50 /

-26.63 (-45.04%)

OTRK Ontrak
$32.50 /

-26.63 (-45.04%)

Hot Stocks
Workhorse Group has scheduled a face-to-face meeting with USPS on March 3 » 10:16
03/01/21
03/01
10:16
03/01/21
10:16
WKHS

Workhorse Group

$15.96 /

-0.23 (-1.42%)

Comments taken from Q4…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WKHS Workhorse Group
$15.96 /

-0.23 (-1.42%)

WKHS Workhorse Group
$15.96 /

-0.23 (-1.42%)

02/24/21
Fly Intel: Top five analyst downgrades
02/24/21 Oppenheimer
Opco downgrades Workhorse after Postal Service snub despite backlog
02/24/21 Roth Capital
Roth cuts Workhorse target to $15 after 'highly unusual' contract loss
02/24/21 Oppenheimer
Workhorse Group downgraded to Perform from Outperform at Oppenheimer
WKHS Workhorse Group
$15.96 /

-0.23 (-1.42%)

WKHS Workhorse Group
$15.96 /

-0.23 (-1.42%)

WKHS Workhorse Group
$15.96 /

-0.23 (-1.42%)

WKHS Workhorse Group
$15.96 /

-0.23 (-1.42%)

Technical Analysis
NYSE market internals summary » 10:16
03/01/21
03/01
10:16
03/01/21
10:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
$0.00 /

+ (+0.00%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.